ACNP - Italian Periodicals Catalogue

AAAAAA

ITA
ENG

Results: 1-25 | 26-27

Results: 1-25/27

PRESERVATIVES IN NEBULIZER SOLUTIONS - RISKS WITHOUT BENEFIT

Authors: BEASLEY R FISHWICK D MILES JF HENDELES L

Citation: R. Beasley et al., PRESERVATIVES IN NEBULIZER SOLUTIONS - RISKS WITHOUT BENEFIT, Pharmacotherapy, 18(1), 1998, pp. 130-139

DOSE-RESPONSE OF INHALED ALBUTEROL DURING NOCTURNAL BRONCHOSPASM

Authors: HENDELES L AHRENS R CLARKE W GEOFFROY P LALONDE R VAUGHAN L HILL M

Citation: L. Hendeles et al., DOSE-RESPONSE OF INHALED ALBUTEROL DURING NOCTURNAL BRONCHOSPASM, Journal of allergy and clinical immunology, 101(1), 1998, pp. 40-40

MONTELUKAST, A LEUKOTRIENE-RECEPTOR ANTAGONIST, FOR THE TREATMENT OF MILD ASTHMA AND EXERCISE-INDUCED BRONCHOCONSTRICTION

Authors: LEFF JA BUSSE WW PEARLMAN D BRONSKY EA KEMP JA HENDELES L DOCKHORN R KUNDU S ZHANG J SEIDENBERG BC REISS TF

Citation: Ja. Leff et al., MONTELUKAST, A LEUKOTRIENE-RECEPTOR ANTAGONIST, FOR THE TREATMENT OF MILD ASTHMA AND EXERCISE-INDUCED BRONCHOCONSTRICTION, The New England journal of medicine, 339(3), 1998, pp. 147-152

ZAFIRLUKAST FOR CHRONIC ASTHMA - CONVENIENT AND GENERALLY SAFE, BUT IS IT EFFECTIVE

Authors: HENDELES L MARSHIK PL

Citation: L. Hendeles et Pl. Marshik, ZAFIRLUKAST FOR CHRONIC ASTHMA - CONVENIENT AND GENERALLY SAFE, BUT IS IT EFFECTIVE, The Annals of pharmacotherapy, 31(9), 1997, pp. 1084-1086

PROPHYLAXIS OF SEIZURES AFTER THEOPHYLLINE OVERDOSE - AUTHORS REPLY

Authors: HENDELES L

Citation: L. Hendeles, PROPHYLAXIS OF SEIZURES AFTER THEOPHYLLINE OVERDOSE - AUTHORS REPLY, Pharmacotherapy, 17(5), 1997, pp. 1045-1045

NEW FRONTIERS IN ASTHMA THERAPY - LEUKOTRIENE RECEPTOR ANTAGONISTS AND 5-LIPOXYGENASE INHIBITORS - INTRODUCTION

Authors: HENDELES L

Citation: L. Hendeles, NEW FRONTIERS IN ASTHMA THERAPY - LEUKOTRIENE RECEPTOR ANTAGONISTS AND 5-LIPOXYGENASE INHIBITORS - INTRODUCTION, Pharmacotherapy, 17(1), 1997, pp. 1-2

USE OF ALLERGEN BRONCHOPROVOCATION TO SCREEN DRUGS FOR ANTIASTHMA ACTIVITY

Authors: HENDELES L HARMAN E

Citation: L. Hendeles et E. Harman, USE OF ALLERGEN BRONCHOPROVOCATION TO SCREEN DRUGS FOR ANTIASTHMA ACTIVITY, Pharmacotherapy, 17(1), 1997, pp. 39-49

RELIABILITY OF THE MEDTRAC MDI CHRONOLOG

Authors: BRUECKNER JW MARSHIK P SHERMAN J HENDELES L

Citation: Jw. Brueckner et al., RELIABILITY OF THE MEDTRAC MDI CHRONOLOG, Journal of allergy and clinical immunology, 100(4), 1997, pp. 488-491

INCREASED URINARY-EXCRETION OF LTE4 AFTER EXERCISE AND ATTENUATION OFEXERCISE-INDUCED BRONCHOSPASM BY MONTELUKAST, A CYSTEINYL LEUKOTRIENERECEPTOR ANTAGONIST

Authors: REISS TF HILL JB HARMAN E ZHANG J TANAKA WK BRONSKY E GUERREIRO D HENDELES L

Citation: Tf. Reiss et al., INCREASED URINARY-EXCRETION OF LTE4 AFTER EXERCISE AND ATTENUATION OFEXERCISE-INDUCED BRONCHOSPASM BY MONTELUKAST, A CYSTEINYL LEUKOTRIENERECEPTOR ANTAGONIST, Thorax, 52(12), 1997, pp. 1030-1035

APPARENT DECREASE IN POPULATION CLEARANCE OF THEOPHYLLINE - IMPLICATIONS FOR DOSAGE

Authors: ASMUS MJ WEINBERGER MM MILAVETZ G MARSHIK P TERESI ME HENDELES L

Citation: Mj. Asmus et al., APPARENT DECREASE IN POPULATION CLEARANCE OF THEOPHYLLINE - IMPLICATIONS FOR DOSAGE, Clinical pharmacology and therapeutics, 62(5), 1997, pp. 483-489

ZILEUTON - A NEW THERAPY FOR ASTHMA OR JUST THE FIRST OF A NEW CLASS OF DRUGS

Authors: HENDELES L MARSHIK PL

Citation: L. Hendeles et Pl. Marshik, ZILEUTON - A NEW THERAPY FOR ASTHMA OR JUST THE FIRST OF A NEW CLASS OF DRUGS, The Annals of pharmacotherapy, 30(7-8), 1996, pp. 873-875

CETIRIZINE - A NEW ANTIHISTAMINE WITH MINIMAL SEDATION

Authors: HENDELES L

Citation: L. Hendeles, CETIRIZINE - A NEW ANTIHISTAMINE WITH MINIMAL SEDATION, Pharmacotherapy, 16(5), 1996, pp. 967-968

SAFETY AND APPROPRIATE USE OF SALMETEROL IN THE TREATMENT OF ASTHMA

Authors: WELCH MJ SZEFLER SJ NELSON HS APTER AJ BRANDON ML CHERVINSKY P HANNAWAY PJ HENDELES L KATZ RM KEMP JP MELAMED J NICKLAS RA ROWE MS SIMONS E WOEHLER TR ZIERING WH

Citation: Mj. Welch et al., SAFETY AND APPROPRIATE USE OF SALMETEROL IN THE TREATMENT OF ASTHMA, Journal of allergy and clinical immunology, 98(3), 1996, pp. 475-480

DOSE-RESPONSE OF INHALED BECLOMETHASONE (B) FOR ATTENUATING THE AIRWAY RESPONSES TO ALLERGEN

Authors: MARSHIK PL THOMAS D AHRENS R BRAVER H HENDELES L

Citation: Pl. Marshik et al., DOSE-RESPONSE OF INHALED BECLOMETHASONE (B) FOR ATTENUATING THE AIRWAY RESPONSES TO ALLERGEN, Journal of allergy and clinical immunology, 97(1), 1996, pp. 534-534

DRUG-THERAPY - THEOPHYLLINE IN ASTHMA

Authors: WEINBERGER M HENDELES L

Citation: M. Weinberger et L. Hendeles, DRUG-THERAPY - THEOPHYLLINE IN ASTHMA, The New England journal of medicine, 334(21), 1996, pp. 1380-1388

REVISED FDA LABELING GUIDELINE FOR THEOPHYLLINE ORAL DOSAGE FORMS

Authors: HENDELES L JENKINS J TEMPLE R

Citation: L. Hendeles et al., REVISED FDA LABELING GUIDELINE FOR THEOPHYLLINE ORAL DOSAGE FORMS, Pharmacotherapy, 15(4), 1995, pp. 409-427

THERAPEUTIC EQUIVALENCE OF A GENERIC SLOW-RELEASE THEOPHYLLINE TABLET

Authors: HENDELES L BRETON AL BEATY R HARMAN E

Citation: L. Hendeles et al., THERAPEUTIC EQUIVALENCE OF A GENERIC SLOW-RELEASE THEOPHYLLINE TABLET, Pharmacotherapy, 15(1), 1995, pp. 26-35

CROMOLYN METERED-DOSE INHALER - REPLY

Authors: HENDELES L HARMAN EM HUANG D OBRIEN R BLAKE K DELAFUENTE J

Citation: L. Hendeles et al., CROMOLYN METERED-DOSE INHALER - REPLY, Journal of allergy and clinical immunology, 96(6), 1995, pp. 1017-1018

PRACTICE PARAMETERS FOR THE DIAGNOSIS AND TREATMENT OF ASTHMA - PREFACE

Authors: SPECTOR SL NICKLAS RA BERNSTEIN IL BLESSINGMOORE J STRUNK RC GUTMAN AA PEARLMAN DS LEE RE FINEMAN S GREEN R HENDELES L LOWENTHAL M SAAVEDRADELGADO AM

Citation: Sl. Spector et al., PRACTICE PARAMETERS FOR THE DIAGNOSIS AND TREATMENT OF ASTHMA - PREFACE, Journal of allergy and clinical immunology, 96(5), 1995, pp. 707-870

THEOPHYLLINE ATTENUATION OF AIRWAY RESPONSES TO ALLERGEN - COMPARISONWITH CROMOLYN METERED-DOSE INHALER

Authors: HENDELES L HARMAN E HUANG D OBRIEN R BLAKE K DELAFUENTE J

Citation: L. Hendeles et al., THEOPHYLLINE ATTENUATION OF AIRWAY RESPONSES TO ALLERGEN - COMPARISONWITH CROMOLYN METERED-DOSE INHALER, Journal of allergy and clinical immunology, 95(2), 1995, pp. 505-514

TREATING ACUTE ASTHMA

Authors: HUANG D HENDELES L

Citation: D. Huang et L. Hendeles, TREATING ACUTE ASTHMA, Chest, 108(2), 1995, pp. 590-591

CLINICAL-PHARMACOLOGY OF PANCREATIC-ENZYMES IN PATIENTS WITH CYSTIC-FIBROSIS AND IN-VITRO PERFORMANCE OF MICROENCAPSULATED FORMULATIONS

Authors: KRAISINGER M HOCHHAUS G STECENKO A BOWSER E HENDELES L

Citation: M. Kraisinger et al., CLINICAL-PHARMACOLOGY OF PANCREATIC-ENZYMES IN PATIENTS WITH CYSTIC-FIBROSIS AND IN-VITRO PERFORMANCE OF MICROENCAPSULATED FORMULATIONS, Journal of clinical pharmacology, 34(2), 1994, pp. 158-166

BIOEQUIVALENCE OF A GENERIC SLOW-RELEASE THEOPHYLLINE TABLET IN CHILDREN

Authors: KANTHAWATANA S AHRENS RC MCCUBBIN M BRONSKY E BLAKE K HENDELES L

Citation: S. Kanthawatana et al., BIOEQUIVALENCE OF A GENERIC SLOW-RELEASE THEOPHYLLINE TABLET IN CHILDREN, The Journal of pediatrics, 125(6), 1994, pp. 987-991

PK PD ANALYSIS OF ALBUTEROL ACTION - APPLICATION TO A COMPARATIVE-ASSESSMENT OF BETA(2)-ADRENERGIC DRUGS/

Authors: HOCHHAUS G HENDELES L HARMAN E MOELLMANN H

Citation: G. Hochhaus et al., PK PD ANALYSIS OF ALBUTEROL ACTION - APPLICATION TO A COMPARATIVE-ASSESSMENT OF BETA(2)-ADRENERGIC DRUGS/, European journal of pharmaceutical sciences, 1(2), 1993, pp. 73-80

SELECTING A DECONGESTANT

Authors: HENDELES L

Citation: L. Hendeles, SELECTING A DECONGESTANT, Pharmacotherapy, 13(6), 1993, pp. 190000129-190000134

Risultati: 1-25 | 26-27